• Publications
  • Influence
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
The 2015 European pulmonary hypertension (PH) guidelines propose a risk stratification strategy for patients with pulmonary arterial hypertension (PAH). Low-, intermediate- and high-risk strata areExpand
Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience
Balloon pulmonary angioplasty (BPA) is an emerging treatment for patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH). We report on a prospective series of 56 consecutiveExpand
Diffusion Capacity and Mortality in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
OBJECTIVES This study sought to investigate the prognostic importance of a low diffusion capacity of the lung for carbon monoxide (DLCO) in patients with a catheter-based diagnosis of pulmonaryExpand
More on idiopathic pulmonary arterial hypertension with a low diffusing capacity
Pulmonary arterial hypertension (PAH) is defined by the presence of pre-capillary pulmonary hypertension (PH) in the absence of underlying causes such as lung diseases, chronic thromboembolicExpand
Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.
BACKGROUND We examined safety and long-term outcomes of intravenous treprostinil administered via the implantable LENUS Pro pump in patients with severe pulmonary hypertension (PH). METHODSExpand
Peritoneal dialysis as therapeutic option in heart failure patients
Each episode of acute decompensated heart failure (HF) incrementally adds to mortality. Peritoneal dialysis (PD) offers an alternative therapeutic option in refractory HF and reduces the incidence ofExpand
Quantitation of Perfused Lung Volume Using Hybrid SPECT/CT Allows Refining the Assessment of Lung Perfusion and Estimating Disease Extent in Chronic Thromboembolic Pulmonary Hypertension
Background We evaluated the feasibility of perfusion SPECT/CT for providing quantitative data for estimation of perfusion defect extent in chronic thromboembolic pulmonary hypertension (CTEPH).Expand
Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension
Portopulmonary hypertension (PoPH) and hepatopulmonary syndrome (HPS) are rare pulmonary vascular complications of portal hypertension [1]. In PoPH, pulmonary vascular resistance (PVR) is elevated,Expand
Diffusion capacity as predictor for survival in patients with pulmonary hypertension due to heart failure with preserved ejection fraction
Background: A low diffusion capacity of the lung for carbon monoxide (DLCO) is associated with poor outcome in patients with pulmonary arterial hypertension. It is unclear if the same is true inExpand